Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Pathophysiologic Changes in the Optic Nerves of Eyes with Primary Open Angle and Pseudoexfoliation Glaucoma
Gottanka, Johannes, Kuhlmann, Alexander , Scholz, Michael , ̈tjen-Drecoll, Elke Lu, Johnson, Douglas H.

Mayo Clinic

Investigative Opthalmology & Visual Science | October 26, 2005 | Volume: 46 | Issue: 11 | Pages: 4170

10.1167/iovs.05-0289 | PMID 16249496 Get It

Extracorporeal shock wave lithotripsy of gallstones: Objectives, current limitations, and preliminary in vitro and in vivo observations
Thistle, Johnson L., Petersen, Bret T.

Mayo Clinic

The Journal of the Acoustical Society of America | October 12, 2005 | Volume: 83 | Issue: S1 | Pages: S89-S89

10.1121/1.2025571 Get It

Surgical removal of gallstones is performed about 500 000 times per year in the United States. Although the usual cost ranges from $5000 to more than $10 000 per patient, the operative mortality is less than 1% for otherwise healthy persons. Nonsurgical dissolution of gallstones is often possible, but many gallstones contain calcium compounds that slow or prevent dissolution using the direct content cholesterol solvent, methyl tertbutyl ether (MTBE). Extracorporeal shock wave lithotripsy (ESL) has potential clinical utility for facilitating dissolution and possibly allowing spontaneous or induced passage of small fragments via the bile ducts and intestines. Obstacles to be overcome include predictable fragmentation of multiple stones up to 3 cm in diameter so that all particles are small enough to be rapidly dissolved or pass safely through the bile ducts (⩽ 3 mm). This must be achieved using biologically tolerable shock wave dosages without requiring general anesthesia within one or two treatment sessions. Acute and chronic safety, patient acceptance, and cost must be competitive with surgical treatment. Initial experience suggests that only solitary noncalcified stones (10% of patients with stones) have a high probability of success using ESL plus oral bile acid dissolution therapy. Improving ESL technology and direct contact fragment dissolution using MTBE should increase the clinical utility of shock wave lithotripsy of gallstones.
Coccidioidomycosis
Galgiani, John N. , Ampel, Neil M. , Blair, Janis E. , Catanzaro, Antonino , Johnson, Royce H. , Stevens, David A. , Williams, Paul L.

Mayo Clinic

Clinical Infectious Diseases | October 5, 2005 | Volume: 41 | Issue: 9 | Pages: 1217-1223

10.1086/496991 | PMID 16206093 Get It

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance
Frost, Marlene H., Slezak, Jeffrey M., Tran, Nho V. , Williams, Constance I., Johnson, Joanne L., Woods, John E., Petty, Paul M., Donohue, John H., Grant, Clive S., Sloan, Jeff A. , Sellers, Thomas A. , Hartmann, Lynn C.

Mayo Clinic

Journal of Clinical Oncology | October 4, 2005 | Volume: 23 | Issue: 31 | Pages: 7849-7856

10.1200/jco.2005.09.233 | PMID 16204003 Get It

Purpose Contralateral prophylactic mastectomy (CPM) is one option for reducing the risk of a second breast cancer in women with a personal and family history of breast cancer. Few data are available regarding satisfaction, psychological, and social function after CPM. The purpose of this research is to evaluate women’s long-term satisfaction with CPM, factors influencing satisfaction, and psychological and social function after CPM. Patients and Methods This was a descriptive study of all women with a family history of breast cancer, known to be alive, who elected CPM at Mayo Clinic (Rochester, MN) between 1960 and 1993 (n = 621). Ninety-four percent of the women (n = 583) completed a study-specific questionnaire. Results A mean of 10.3 years after the procedure, the majority of women (83%) were satisfied with their CPM. A smaller number were neutral (8%) or dissatisfied (9%). Women who had a subcutaneous mastectomy had more problems with reconstruction, and fewer of these women were satisfied than women with simple mastectomy. Decreased satisfaction with CPM was associated with decreased satisfaction with appearance, complications with reconstruction, reconstruction after CPM, and increased level of stress in life. The majority of women experienced no change or favorable effects in self-esteem (83%), level of stress in life (83%), and emotional stability (88%). Satisfaction with body appearance, feelings of femininity, and sexual relationships were the most adversely affected with 33%, 26%, and 23% of the women responding negatively. Conclusion Although most women are satisfied with CPM, each woman should weigh the benefits alongside the potential adverse effects.
Computer studies of linear and nonlinear processing for reflection tomographic data: Extension of synthetic focus imaging methods for medicine
Johnson, Steven A., Greenleaf, J. F., Rajagopalan, B., Tanaka, Mitsuru

Mayo Clinic

The Journal of the Acoustical Society of America | October 3, 2005 | Volume: 64 | Issue: S1 | Pages: S177-S177

10.1121/1.2004037 Get It

Data and simulated data from circumscribing and linear sampled arrays has been used to form high resolution reflection images by two techniques. The first technique (synthetic focusing) uses the mathematical equivalent of a lense to focus the image at each point by adding either linear (uncompressed) or nonlinear (compressed) transforms of the data. Logarithmic and square root compression is studied. The lense effect is obtained by backprojecting convolved or other linear transformed versions of the data along equal time propagation surfaces in the image with appropriate corrections for refraction and frequency dependent attenuation. The choice of apodizing function and different wave forms can greatly improve image resolution. The second technique (reflection ART) is not based on a focusing model but rather on direct inversion of a matrix (linear transform) model of the object-acoustic field interaction and data acquisition process by a Kacmarz iterative inversion method. The two methods are compared.
Ultrasound imaging for characterization of biological tissue and function
Rajagopalan, Balu, Greenleaf, James F., Johnson, Stephen A.

Mayo Clinic

The Journal of the Acoustical Society of America | October 3, 2005 | Volume: 63 | Issue: S1 | Pages: S38-S39

10.1121/1.2016628 Get It

Quantitative images of acoustic speed distribution in excised human tissues, in excised dog myocardium, and in in vivo female breasts were obtained by ultrasound computerized tomography. The in vitro study was carried over a temperature from 20° to 40 °C. Results indicate (1) acoustic speed in human tissues (except fat) increase monotonically with temperature in this range, (2) fat shows an anomalous decrease in acoustic speed around 35 °C, (3) average acoustic speed is higher in breasts with cancer and with fibrocystic disease compared to normal breasts, and (4) acoustic speed is a function of age. The reconstruction problem in ultrasound computerized tomography is unlike its x-ray analog because of the refraction and diffraction effects. Methods to correct for the consequent degradation are discussed. The backscattering properties of in vivo myocardial tissue of dogs were studied by a high-resolution B-scanner and the potential of (renovist and indocyanine green) as ultrasound contrast agents to quantitate perfusion in the myocardium will be discussed. [Work supported by NCI-CB-64041, HV 72928, HL-07111, HL-00060, HL-00170.]
Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus
Johnson, Kenneth L. , Ovsyannikova, Inna G. , Muddiman, David C. , Madden, Benjamin J. , Poland, Gregory A.

Mayo Clinic

Journal of the American Society for Mass Spectrometry | September 27, 2005 | Volume: 16 | Issue: 11 | Pages: 1812-1817

10.1016/j.jasms.2005.07.015 | PMID 16185891 Get It

Genetically Characterized Positive Control Cell Lines Derived from Residual Clinical Blood Samples
Bernacki, Susan H. , Beck, Jeanne C., Stanković, Ana , Williams, Laurina O. , Amos, Jean, Snow-Bailey, Karen, Farkas, Daniel H., Friez, Michael J., Hantash, Feras, Matteson, Karla J., Monaghan, Kristin G. , Muralidharan, Kasinathan, Pratt, Victoria M. , Prior, Thomas W., Richie, Kristy L., Levin, Barbara C., Rohlfs, Elizabeth M., Schaefer, Frederick V., Shrimpton, Antony E., Spector, Elaine , Stolle, Catherine A., Strom, Charles M. , Thibodeau, Stephen N. , Cole, Eugene C., Goodman, Barbara K. , Stenzel, Timothy T.

Mayo Clinic

Clinical Chemistry | September 16, 2005 | Volume: 51 | Issue: 11 | Pages: 2013-2024

10.1373/clinchem.2005.048694 | PMID 16166172 Get It

AbstractBackground: Positive control materials for clinical diagnostic molecular genetic testing are in critically short supply. High-quality DNA that closely resembles DNA isolated from patient specimens can be obtained from Epstein–Barr virus (EBV)–transformed peripheral blood lymphocyte cell lines. Here we report the development of a process to (a) recover residual blood samples with clinically important mutations detected during routine medical care, (b) select samples likely to provide viable lymphocytes for EBV transformation, (c) establish stable cell lines and confirm the reported mutation(s), and (d) validate the cell lines for use as positive controls in clinical molecular genetic testing applications.Methods: A network of 32 genetic testing laboratories was established to obtain anonymous, residual clinical samples for transformation and to validate resulting cell lines for use as positive controls. Three panel meetings with experts in molecular genetic testing were held to evaluate results and formulate a process that could function in the context of current common practices in molecular diagnostic testing.Results: Thirteen laboratories submitted a total of 113 residual clinical blood samples with mutations for 14 genetic disorders. Forty-one EBV-transformed cell lines were established. Thirty-five individual point and deletion mutations were shown to be stable after 20 population doublings in culture. Thirty-three cell lines were characterized for specific mutations and validated for use as positive controls in clinical diagnostic applications.Conclusions: A process for producing and validating positive control cell lines from residual clinical blood samples has been developed. Sustainable implementation of the process could help alleviate the current shortage of positive control materials.